Ligand based pharmacophore design synthesis of novel histone deacetylase inhibitors and their evaluation for antineoplastic potential

dc.contributor.guide	Chandrasekar, M J N
dc.coverage.spatial	Pharmacy
dc.creator.researcher	Mohammed, Manal
dc.date.accessioned	2019-09-09T11:47:36Z
dc.date.available	2019-09-09T11:47:36Z
dc.date.awarded	15-10-2018
dc.date.completed	2017
dc.date.registered	2014
dc.description.abstract	available
dc.description.note	quotsummary p 118-119, References p 120-130quot
dc.format.accompanyingmaterial	CD
dc.format.dimensions	3
dc.format.extent	i-xv, 1-134 p
dc.identifier.uri	http://hdl.handle.net/10603/257023
dc.language	English
dc.publisher.institution	Colleges of Pharmacy
dc.publisher.place	Mysore
dc.publisher.university	JSS Academy of Higher Education and Research
dc.relation	121
dc.rights	university
dc.source.university	University
dc.subject.keyword	Clinical Pre Clinical and Health,Pharmacology and Toxicology,Pharmacology and Pharmacy
dc.subject.keyword	Histone deacetylase, HDAC inhibitors, molecular docking, drug likeliness, DFT, neoplasms, enzyme inhibition.
dc.title	Ligand based pharmacophore design synthesis of novel histone deacetylase inhibitors and their evaluation for antineoplastic potential
dc.title.alternative
dc.type.degree	Ph.D.